Physician profile
Daniel Botros
NPI 1629538905
$23,871.48
in general payments reported to CMS, 2019-2025
12 companies · $8,758 in 2025
The $8,758 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $312 · 2023: $2,787 · 2024: $12K · 2025: $8,758.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Travel and Lodging: $8,895 · Food and Beverage: $4,665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Travel and Lodging | $8,894.82 |
| Food and Beverage | $4,664.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $10,130.66 | 2024-2025 | Trigen Intertan |
| Stryker Corporation | $4,650.43 | 2022-2025 | Pro, Mako, Pelvis II |
| Zimmer Biomet Holdings, INC. | $3,109.56 | 2023-2025 | Avenir, Affixus |
| Arthrex, INC. | $2,400.83 | 2023-2025 | |
| Medical Device Business Services, INC. | $2,216.69 | 2024 | Va-Lcp |
| Globus Medical, INC. | $621.91 | 2024-2025 | Autobahn, Anthem, Stretto |
| Depuy Synthes Sales INC. | $190.84 | 2024-2025 | Na, Va-Lcp |
| Si-Bone, INC. | $162.25 | 2023 | |
| Curvafix, INC. | $140.00 | 2025 | Curvafix Im Implant |
| Orthalign INC | $130.91 | 2024 | Orthalign Plus |
| Polaris Technology Solutions LLC | $97.66 | 2023 | |
| Mid-Atlantic Surgical Systems, LLC | $19.74 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Botros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.